# Quercetin attenuates acute alcohol-induced liver injury in mice by modulating lipid metabolism, oxidative stress, and inflammation

**Authors:** Wenjing He, Binbin Zhang, Siwei Li, Yuanyuan Qian

PMC · DOI: 10.3389/fphar.2026.1702639 · Frontiers in Pharmacology · 2026-02-18

## TL;DR

Quercetin, a natural compound, protects mice from alcohol-induced liver damage by reducing fat buildup, inflammation, and oxidative stress.

## Contribution

This study reveals quercetin's novel protective mechanisms in acute alcohol-induced liver injury through lipid metabolism and inflammation modulation.

## Key findings

- High-dose quercetin reduced liver enzymes, fat levels, and inflammatory markers in mice with alcohol-induced injury.
- Quercetin altered gene and protein expression to enhance fat metabolism and reduce liver fat accumulation.
- Histological evidence confirmed reduced liver steatosis following quercetin treatment.

## Abstract

Alcoholic liver disease (ALD) remains a major global health burden, and effective therapeutic options are limited. Quercetin, a dietary flavonoid with antioxidant and anti-inflammatory properties, has shown hepatoprotective potential, but its mechanisms in acute alcohol-induced liver injury require clarification.

Fifty male BALB/c mice were randomly divided into five groups (n = 10/group): control (CG), model (MG), low-dose quercetin (LQ, 50 mg/kg), high-dose quercetin (HQ, 100 mg/kg), and oyster soybean carnitine mice in the oyster soybean carnitine group (OG) were administered oyster soybean carnitine at a volume of 20 mL/kg.(OG, 20 mL/kg). All treatments were administered orally once daily for 14 days. Acute alcohol injury was induced on Day 14 using 52% (v/v) ethanol. Behavioral intoxication indices, serum biochemistry, liver oxidative stress markers, inflammatory cytokines, histopathology, lipid accumulation, and the expression of lipid-metabolismrelated genes and proteins (FAS, SCD1, ACC1, CPT1, PGC-1α, PPARα) were assessed.

HQ significantly prolonged alcohol tolerance time (P < 0.01) and shortened sober-up time (P < 0.01). HQ markedly reduced serum AST, ALT, TG, FFA, and glycerol levels (P < 0.01). Quercetin also lowered hepatic TG, TNF-α, and IL-6 and increased SOD, GSH, and CAT activities. Histological and Oil Red O staining confirmed reduced steatosis. Mechanistically, quercetin downregulated hepatic FAS, SCD1, and ACC1 while upregulating CPT1, PGC-1α, and PPARα at both mRNA and protein levels.

Quercetin exerts hepatoprotective effects against acute alcohol-induced liver injury through coordinated regulation of lipid metabolism, oxidative stress, and inflammatory responses.The study did not include a quercetin-only group or measure blood ethanol levels, which should be addressed in future work.These findings support the potential of quercetin as a natural candidate for preventing alcohol-related hepatic injury.

## Linked entities

- **Genes:** FAS (Fas cell surface death receptor) [NCBI Gene 355], SCD (stearoyl-CoA desaturase) [NCBI Gene 6319], ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31], CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465]
- **Proteins:** SOD1 (superoxide dismutase 1), LOC23687505 (pyrimidodiazepine synthase), CAT (catalase)
- **Chemicals:** quercetin (PubChem CID 5280343), ethanol (PubChem CID 702), ALT (PubChem CID 10219674), TG (PubChem CID 2723601), FFA (PubChem CID 3371), glycerol (PubChem CID 753), IL-6 (PubChem CID 165368475)
- **Diseases:** alcoholic liver disease (MONDO:0043693)

## Full-text entities

- **Genes:** Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Fasn (fatty acid synthase) [NCBI Gene 14104] {aka A630082H08Rik, FAS}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Nup62 (nucleoporin 62) [NCBI Gene 18226] {aka D7Ertd649e, Nupc1, p62}, Acaca (acetyl-Coenzyme A carboxylase alpha) [NCBI Gene 107476] {aka A530025K05Rik, Acac, Acc1, Gm738}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, catalase [NCBI Gene 100037447], Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 66734] {aka 1010001H21Rik, 4922501H04Rik, LC3, LC3a}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Cpt1b (carnitine palmitoyltransferase 1b, muscle) [NCBI Gene 12895] {aka Cpt1, Cpt1-m, Cpti, Cpti-m, M-cpti}, Becn1 (beclin 1, autophagy related) [NCBI Gene 56208] {aka Atg6}, Scd1 (stearoyl-Coenzyme A desaturase 1) [NCBI Gene 20249] {aka Scd, Scd-1, ab}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}
- **Diseases:** lipid (MESH:D011017), liver injury (MESH:D017093), acute liver damage (MESH:D056486), alcohol intoxication (MESH:D000435), ALD (MESH:D008108), binge (MESH:D002032), acute liver injury (MESH:D017114), alcoholic hepatitis (MESH:D006519), cardiovascular disease (MESH:D002318), thrombotic (MESH:D013927), acute alcohol-related (OMIM:610251), MG (MESH:D004195), autoimmune diseases (MESH:D001327), hepatic steatosis (MESH:D005234), induced (MESH:D000092582), diabetes (MESH:D003920), cancer (MESH:D009369), NAFLD (MESH:D065626), alcohol injury (MESH:D000437), cirrhosis (MESH:D005355), hepatic metabolic disorder (MESH:D008107), Inflammatory (MESH:D007249)
- **Chemicals:** reactive oxygen species (MESH:D017382), flavonoid (MESH:D005419), PVDF (MESH:C024865), alcohol (MESH:D000438), eosin (MESH:D004801), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), sodium carboxymethyl cellulose (MESH:D002266), GSH (MESH:D005978), MDA (MESH:D008315), fatty acid (MESH:D005227), glycerol (MESH:D005990), L-carnitine (MESH:D002331), Hematoxylin (MESH:D006416), TG (MESH:D013866), H&amp;E (MESH:D006371), CMC-Na (-), Ethanol (MESH:D000431), SDS (MESH:D012967), Oil Red O (MESH:C011049), FFA (MESH:D005230), isoflurane (MESH:D007530), water (MESH:D014867), polyacrylamide (MESH:C016679), Triglyceride (MESH:D014280), Quercetin (MESH:D011794), paraffin (MESH:D010232)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Mus musculus (house mouse, species) [taxon 10090], Glycine max (soybean, species) [taxon 3847]
- **Mutations:** C-23  C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12957255/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12957255/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12957255/full.md

---
Source: https://tomesphere.com/paper/PMC12957255